Sort   by:  
 Page size 
UnknownSignificant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.
Not available
S-EPMC4486342 | biostudies-literature
UnknownIntegrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes.
Not available
S-EPMC9470534 | biostudies-literature
UnknownGenome-wide meta-analyses of smoking behaviors in African Americans.
Not available
S-EPMC3365260 | biostudies-literature
UnknownDevelopment and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Not available
S-EPMC7572656 | biostudies-literature
UnknownGenome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease.
Not available
S-EPMC10915171 | biostudies-literature
UnknownEvidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.
Not available
S-EPMC4264456 | biostudies-literature
UnknownPrognostic gene expression signature for high-grade serous ovarian cancer.
Not available
S-EPMC7484370 | biostudies-literature
UnknownCopy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.
Not available
S-EPMC9949586 | biostudies-literature
UnknownBeyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinoma.
Not available
S-EPMC12486008 | biostudies-literature
UnknownAn original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Not available
S-EPMC4478717 | biostudies-literature
Sort   by:  
 Page size